Chemokine receptor V δ32 deletion in multiple sclerosis patients in Csongrád County in Hungary and the North-Bácska region in Serbia

Nóra Török, Kinga Molnár, Judit Füvesi, Mária Karácsony, Viktória Zsiros, Annamária Fejes-Szabó, Szilvia Fiatal, Róza Ádány, Ferenc Somogyvári, Olivera Stojiljković, László Vécsei, Krisztina Bencsik

Research output: Article

1 Citation (Scopus)


The roles of chemokine receptor V (CCR5) and its polymorphism, rs333 in multiple sclerosis (MS) are controversial. We investigated the receptor and its deletion in a large MS (428) and a numerous control (831) population in Csongrád County (Hungary) and North-Bácska (Serbia). Taqman probes firstly were used for the allele discrimination. There was no significant difference in genotype (OR. =. 1.092, 95% CI. =. 0.807-1.478, p=. 0.568 for wt/wt (wt. =. wild type allele) vs wt/δ32, δ32/δ32 (δ32. =. δ32 base pair deletion allele)) or allele frequency (OR. =. 0.914, 95% CI. =. 0.692-1.207, p=. 0.525). Neither the deletion nor the wt allele affected the Expanded Disability Status Scale score or the age at onset. Our results indicate no association between the CCR5 δ32 allele and MS.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalHuman Immunology
Issue number1
Publication statusPublished - jan. 1 2015


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this